Top Markets
#1 Akedo Akedo +59.54%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.99%
#4 Velvet Velvet +41.93%
#5 Black Phoenix Black Phoenix +34.52%
#6 τemplar τemplar +26.67%
#7 Ribbita by Virtuals Ribbita by Virtuals +18.08%
#8 Bitway Bitway +17.19%
#9 Cap Cap +17.11%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.52%
Coin of the day
Akedo Akedo
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
Pozycja w akcjach #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Cena akcji
$0.08765138
Ostatnia synchronizacja: 2025-12-23
Kapitalizacja rynkowa
$1.11M
Zmiana (1 dzień)
0.45%
Zmiana (1 rok)
-28.78%
Kraj
CA
Handel Psyence Group Inc. (PSYG)

Kategoria

Healthcare
Historia stopy dywidendy dla Psyence Group Inc. (PSYG)
Stopa dywidendy (TTM) dla Psyence Group Inc. (symbol akcji: PSYG) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Psyence Group Inc. (PSYG) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
0.56%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
2.04%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
2.72%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
2.69%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
2.58%
US